Stimulating blood vessel formation with magnets

TSUKUBA, Japan, Jul 22, 2021 - (ACN Newswire) - Magnetic field can be used to stimulate blood vessel growth, according to a study published in the journal Science and Technology of Advanced Materials. The findings, by researchers at the Tecnico Lisboa and NOVA School of Science and Technology in Portugal, could lead to new treatments for cancers and help regenerate tissues that have lost their blood supply.

Human-donated mesenchymal stromal cells were placed on PVA or gelatin hydrogels containing iron oxide nanoparticles. Applying a magnetic field to the gelatin hydrogel triggered the release of VEGF-A. This was used to treat endothelial cells, stimulating blood vessel formation.

"Researchers have found it challenging to develop functional, vascularized tissue that can be implanted or used to regenerate damaged blood vessels," says Frederico Ferreira, a bioengineer at Tecnico Lisboa's Institute for Biosciences and Bioengineering. "We developed a promising cell therapy alternative that can non-invasively stimulate blood vessel formation or regeneration through the application of an external low-intensity magnetic field."

The researchers worked with human mesenchymal stromal cells from bone marrow. These cells can change into different cell types, and also secrete a protein called VEGF-A that stimulates blood vessel formation.

Ana Carina Manjua and Carla Portugal, at the Research Centre LAQV at the NOVA School of Science and Technology, developed two hydrogel supports, made from polyvinyl alcohol (PVA) or gelatin, both containing iron oxide nanoparticles. Cells were cultured on the hydrogels and exposed to a low-intensity magnetic field for 24 hours.

The cells on the PVA hydrogel produced less VEGF-A after the magnetic treatment. But the cells on the gelatin hydrogel produced more. Subsequent lab tests showed that this VEGF-A rich extracts, taken from the cultures on magnet-stimulated gelatin hydrogel, improved the ability of human vascular endothelial cells to sprout into branching blood vessel networks.

Endothelial cells were then placed onto a culture dish with a gap separating them. The conditioned media from magnet-treated mesenchymal stromal cells from the gelatin hydrogel were added to the endothelial cells, moving to close the gap between them in 20 hours. This was significantly faster than the 30 hours they needed when they had not received magnetic treatment. Placing a magnet directly below the dish triggered the mesenchymal stromal cells to close the gap in just four hours.

Finally, VEGF-A extracts produced by magnet-treated mesenchymal stromal cells on gelatin increased blood vessel formation in a chick embryo, although further research is needed to confirm these results.

More work is needed to understand what happens at the molecular level when a magnetic field is applied to the cells. But the researchers say gelatin hydrogels containing iron oxide nanoparticles and mesenchymal stromal cells could one day be applied to damaged blood vessels and then exposed to a short magnetic treatment to heal them.

The team suggests that magnet-treated cells on PVA, which produce less of the growth factor, could be used to slow down blood vessel growth to limit the expansion of cancer cells.

Further informationFrederico Castelo FerreiraUniversidade de LisboaEmail: frederico.ferreira@ist.utl.pt

Carla Portugal Universidade Nova de LisboaEmail: cmp@fct.unl.pt

Ana Carina Baeta ManjuaUniversidade de LisboaEmail: carina.manjua@tecnico.ulisboa.pt

About Science and Technology of Advanced Materials Journal

Open access journal STAM publishes outstanding research articles across all aspects of materials science, including functional and structural materials, theoretical analyses, and properties of materials. Website: https://www.tandfonline.com/toc/tsta20/current

Dr. Yoshikazu ShinoharaSTAM Publishing DirectorEmail: SHINOHARA.Yoshikazu@nims.go.jp

Press release distributed by ResearchSEA for Science and Technology of Advanced Materials.

Copyright 2021 ACN Newswire. All rights reserved. www.acnnewswire.com